SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for the beneficial effects of polyphenols on hepatic lipid accumulation, hyperlipidemia, and atherosclerosis in type 1 diabetic mice, we hypothesize that polyphenol-activated SIRT1 acts upstream of AMPK signaling and hepatocellular lipid metabolism. Here we show that polyphenols, including resveratrol and the synthetic polyphenol S17834, increase SIRT1 deacetylase activity, LKB1 phosphorylation at Ser(428), and AMPK activity. Polyphenols substantially prevent the impairment in phosphorylation of AMPK and its downstream target, ACC (acetyl-CoA carboxylase), elevation in expression of FAS (fatty acid synthase), and lipid accumulation in human HepG2 hepatocytes exposed to high glucose. These effects of polyphenols are largely abolished by pharmacological and genetic inhibition of SIRT1, suggesting that the stimulation of AMPK and lipid-lowering effect of polyphenols depend on SIRT1 activity. Furthermore, adenoviral overexpression of SIRT1 stimulates the basal AMPK signaling in HepG2 cells and in the mouse liver. AMPK activation by SIRT1 also protects against FAS induction and lipid accumulation caused by high glucose. Moreover, LKB1, but not CaMKKbeta, is required for activation of AMPK by polyphenols and SIRT1. These findings suggest that SIRT1 functions as a novel upstream regulator for LKB1/AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism. Targeting SIRT1/LKB1/AMPK signaling by polyphenols may have potential therapeutic implications for dyslipidemia and accelerated atherosclerosis in diabetes and age-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SIRT1 crosstalks with the mTOR and AMPK pathways by interacting with hamartin–tuberin and deacetylating LKB1”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Cited by
Items 201–300 of 790
Erythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System
Wang, L., Di, L., & Noguchi, C. T. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9518 · Cited by 96
“For example, Sirt1 directly deacetylates the AMPK protein kinase liver kinase B1 to increase the activity of AMPK to regulate hepatocyte lipid metabolism and improve systemic insulin sensitivity [193, 194].”
BackgroundLKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
Zhang, Y., Meng, Q., Sun, Q., Xu, Z., Zhou, H., & Wang, Y. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101131 · Cited by 97
Ma, J., Guillot, A., Yang, Z., Mackowiak, B., Hwang, S., Park, O., Peiffer, B. J., Ahmadi, A. R., Melo, L., Kusumanchi, P., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157780 · Cited by 90
“NAD+-dependent deacetylase SIRT1 regulates hepatocyte lipid synthesis through AMPK activation (35, 36).”
Self-citationBottani, E., Lamperti, C., Prigione, A., Tiranti, V., Persico, N., & Brunetti, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111083 · Cited by 96
“Other authors instead reported that RSV might first activate SIRT1 in vivo, leading to AMPK activation [121,122], and deacetylation of PGC-1α [114].”
BackgroundBiochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes
Oza, M. J., & Kulkarni, Y. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.073 · Cited by 96
Woller, A., Duez, H., Staels, B., & Lefranc, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.060 · Cited by 84
“In this scheme, the action of SIRT1 on AMPK via LKB1 does not appear explicitly, but can be taken into account through the shape of the AMPKprofile.”
BackgroundKim, Y., Kim, Y., Kang, S.-S., Cho, G.-J., & Choi, W.-S. (2010) · Diabetes · doi:10.2337/db09-1431 · Cited by 90
“Sirtuin 1 (SIRT1) and activator of AMP-activated protein kinase (AMPK), which are activated by resveratrol, have been described as key contributors to the protective effects of resveratrol in diabetic pathophysiology (1921, 35).”
BackgroundResveratrol: botanical origin, pharmacological activity and applications
Wu, C., Yang, J., Wang, F., & Wang, X. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60001-1 · Cited by 106
Li, J., Li, W., Li, J., Li, Y., Song, H., Luan, Y., Qi, H., Ma, L., Lü, X., & Yang, Y. (2016) · Scientific Reports · doi:10.1038/srep36209 · Cited by 91
Dietary Polyphenols and Mitochondrial Function: Role in Health and Disease
Teixeira, J., Chavarria, D., Borges, F., Wojtczak, L., Wieckowski, M. R., Karkucińska‐Więckowska, A., & Oliveira, P. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170529101810 · Cited by 93
GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease
Lee, J., Hong, S.-W., Rhee, E.-J., & Lee, W.-Y. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.4.262 · Cited by 87
“Recent studies reported that GLP-1 increases the phosphorylation of AMPK in hepatocytes and reverses hepatic steatosis by stimulating fatty acid oxidation [8,31,32].”
BackgroundRogacka, D., Audzeyenka, I., Rychłowski, M., Rachubik, P., Szrejder, M., Angielski, S., & Piwkowska, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.014 · Cited by 90
Banerjee, J., Bruckbauer, A., & Zemel, M. B. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.011 · Cited by 86
“[25] Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, et al.”
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
“Another compound potentially displaying a broad profile of effects is S17834 (23), a polyphenol inhibitor of superoxide formation by Nox with an IC50 > 25 lM, which also increases SIRT1 deacetylase activity, LKB1 phosphorylation at Ser428, and AMPK activity (74, 177, 178).”
BackgroundJung, T. W., Lee, K., Lee, M. W., & Ka, K.-H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.129 · Cited by 89
Ren, Z., Xie, Z., Cao, D., Gong, M., Yang, L., Zhou, Z., & Ou, Y. (2018) · Food & Function · doi:10.1039/c8fo00257f · Cited by 89
So, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83
Sirtuin 1: A Target for Kidney Diseases
Kong, L., Wu, H., Zhou, W., Luo, M., Tan, Y., Miao, L., & Cai, L. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00211 · Cited by 87
“Overexpression of SIRT1 stimulated the AMPK phosphorylation (147), whereas shRNA-mediated SIRT1 knockdown reduced AMPK phosphorylation (148).”
BackgroundKurtz, C. L., Fannin, E. E., Toth, C. L., Pearson, D. S., Vickers, K. C., & Sethupathy, P. (2015) · Scientific Reports · doi:10.1038/srep12911 · Cited by 91
“In addition to Ahr, the transcription factor forkhead box O3 (Foxo3) and the sirtuin family of NAD-dependent deacetylases have also been linked to the suppression of hepatic lipid synthesis 33,34 .”
BackgroundMorales-Alamo, D., Ponce-González, J. G., Guadalupe-Grau, A., Rodríguez-García, L., Santana, A., Cusso, M. R., Guerrero, M., Guerra, B., Dorado, C., & Calbet, J. A. L. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00415.2012 · Cited by 78
“Increased levels of cellular cAMP may blunt Thr 172 -AMPK (cid:1) phosphorylation by inhibition of Ca 2 (cid:2) /calmodulin-dependent kinase kinase-(cid:4) [an AMPK kinase (29)] but not LKB1 (33).”
BackgroundInfluentialAlcohol-induced protein hyperacetylation: Mechanisms and consequences
Shepard, B.-D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1219 · Cited by 83
Cho, J., Lee, I., Kim, D., Koh, Y., Kong, J., Lee, S., & Kang, H. (2014) · Journal of Exercise Nutrition and Biochemistry · doi:10.5717/jenb.2014.18.4.339 · Cited by 83
“SIRT1, a NAD + dependent histone/protein deacetylase, is a stimulator of pAMPK expression, implying that increased SIRT1 expression could have contributed to attenuated HFD-induced lipid accumulation in the liver by upregulating and/or activating AMPK [24].”
BackgroundThe controversial links among calorie restriction, SIRT1, and resveratrol
Hu, Y., Liu, J., Wang, J., & Liu, Q. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.034 · Cited by 93
“Mechanistic studies indicated that resveratrol could increase AMPK phosphorylation and the beneficial effects of resveratrol might depend on AMPK activation [26,77,99–102].”
BackgroundRemogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
Nakano, S., Katsuno, K., Isaji, M., Nagasawa, T., Buehrer, B. M., Walker, S., Wilkison, W. O., & Cheatham, B. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.02.005 · Cited by 89
Potenza, M. A., Sgarra, L., Nacci, C., Leo, V., Salvia, M. A. D., & Montagnani, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210654 · Cited by 83
“In turn, by promoting lysine deacetylation of LKB1 and subsequent translocation from nucleus to cytoplasm, SIRT-1 may sustain the LKB1-mediated activation of AMPK [63].”
BackgroundA comprehensive review of Sirtuins: With a major focus on redox homeostasis and metabolism
Shahgaldi, S., & Kahmini, F. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119803 · Cited by 88
Guerra, B., Guadalupe-Grau, A., Fuentes, T., Ponce-González, J. G., Morales-Alamo, D., Olmedillas, H., Guillén-Salgado, J., Santana, A., & Calbet, J. A. L. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1413-y · Cited by 81
“Thus, in both sprints, there was a very high glycolytic rate, which should have elicited a marked elevation of the NAD+/NADH.”
BackgroundInfluentialNelson, L. E., Valentine, R. J., Cacicedo, J. M., Gauthier, M.-S., Ido, Y., & Ruderman, N. B. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2011 · Cited by 79
“Since both AMPK and SIRT1 have lipid-lowering effects in vitro and in vivo (8, 12, 22, 35, 60, 62), we hypothesized that p53 overexpression would attenuate the lipid-lowering effect of metformin.”
BackgroundMethodSelf-citationTang, Y., Zhao, R., Pu, Q., Jiang, S., Yu, F., Yang, Z., & Han, T. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164808 · Cited by 80
Resveratrol in Cholesterol Metabolism and Atherosclerosis
Voloshyna, I., Hussaini, S. M. A., & Reiss, A. B. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0025 · Cited by 83
“92,93 Resveratrol also increases metabolic rate, insulin sensitivity, and glucose tolerance while reducing fat mass in control mice but not in AMPK-deficient mice.”
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 77
“…al. 2006), recent work has shown that many of the favourable effects of polyphenols, particularly in relation to hepatic lipid metabolism, occur in an AMPK-dependent manner (Hou et al. 2008), indicating that AMPK signalling is likely involved in the insulin-sensitizing effects of these compounds.”
BackgroundCardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins
Dolinsky, V. W., Cole, L., Sparagna, G. C., & Hatch, G. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.008 · Cited by 85
Dihingia, A., Ozah, D., Ghosh, S., Sarkar, A., Baruah, P. K., Kalita, J., Sil, P. C., & Manna, P. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.022 · Cited by 78
SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol
Fullerton, M. D., & Steinberg, G. R. (2010) · Diabetes · doi:10.2337/db09-1732 · Cited by 77
Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming
Sato, T., & Sassone‐Corsi, P. (2022) · EMBO Reports · doi:10.15252/embr.202152412 · Cited by 81
Insulin resistance due to nutrient excess: Is it a consequence of AMPK downregulation?
Saha, A. K., Xu, X. J., Balon, T. W., Brandon, A., Kraegen, E. W., & Ruderman, N. B. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17886 · Cited by 77
Yang, S. J., Choi, J. M., Chae, S. W., Kim, W. J., Park, S. E., Rhee, E., Lee, W., Oh, K. W., Park, S. W., Kim, S. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017057 · Cited by 80
“Several lines of evidence suggest that Sirt1 may function in part by activating AMPK [23,24], which is one of the suggested mechanisms underlying TZD’s beneficial effects.”
BackgroundFarghali, H., Canová, N. K., & Lekić, N. (2013) · Physiological Research · doi:10.33549/physiolres.932434 · Cited by 81
“For example, the evidence for a SIRT1/LKB1/AMPK signaling mechanism was reported by Hou et al. (2008) who demonstrated that the ability of polyphenols (resveratrol, SI 17834) to activate AMPK in cultured HepG2 cells and mouse liver in vivo required the presence of both SIRT1 and LKB1.”
BackgroundAldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway
Pal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0080 · Cited by 82
Shulga, N., & Pastorino, J. G. (2010) · Journal of Cell Science · doi:10.1242/jcs.073502 · Cited by 75
“The phytoalexin resveratrol, which activates sirtuin-1, alleviated the onset of alcoholic fatty liver in mice fed an ethanol-containing diet (Ajmo et al., 2008; Hou et al., 2008).”
RetractedGan, R., & Li, H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916698 · Cited by 80
“In HepG2 cells and mouse liver, over-expression of SIRT1 can stimulate basal AMPK signaling via phosphorylation and activation of LKB1 [77].”
BackgroundBastin, J., Lopes-Costa, A., & Djouadi, F. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr089 · Cited by 72
Controlling the master—upstream regulation of the tumor suppressor LKB1
Kullmann, L., & Krahn, M. P. (2018) · Oncogene · doi:10.1038/s41388-018-0145-z · Cited by 75
“hepatic overexpression of SIRT1 leads to an elevated activation of AMPK [100].”
Zhang, Z.-F., Fan, S., Zheng, Y., Lu, J. L., Wu, D., Shan, Q., & Hu, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.002 · Cited by 83
“These results indicated that troxerutin strikingly rescued defects in lipin 1 signaling via activating AMPK to inhibit mTORC1 signaling in HFD-treated mouse livers, which was mediated by SirT1 up-regulation.”
BackgroundInfluentialResveratrol vs. calorie restriction: Data from rodents to humans
Lam, Y. Y., Peterson, C. M., & Ravussin, É. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.005 · Cited by 87
“…and SIRT1 (Canto et al., 2009; Feige et al., 2008; Um et al., 2010), SIRT1 has been shown as an upstream regulator of the LKB1/AMPK signaling pathway in HepG2 cells (Hou et al., 2008; Lan et al., 2008) and similarly AMPK activation is SIRT1-dependent in 3T3-L1 adipocytes (Chakrabarti et al., 2011).”
BackgroundPark, S., Mori, R., & Shimokawa, I. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0130-x · Cited by 71
“Additional studies showed that SIRT1 inhibits acetyl-CoA carboxylase and fatty acid synthase by activation of AMP-activated protein kinase (AMPK) and suppresses lipid accumulation in liver (Hou et al., 2008; Starai et al., 2002).”
BackgroundKang, H., & Kim, B. (2023) · Foods · doi:10.3390/foods12050925 · Cited by 86
“NR inactivated HIF-1α by deacetylation [206] and repressed its downstream genes, such as GLUT1, pyruvate dehydrogenase kinase 1 (PDK1), and lactate dehydrogenase α (LDHα), which were increased in macrophages upon ethanol exposure [31,53].”
BackgroundInfluentialMouchiroud, L., Molin, L., Dallière, N., & Solari, F. (2010) · BioFactors · doi:10.1002/biof.127 · Cited by 73
“Indeed, data obtained in condition of chronic treatment by RSV of hepatocytes suggest that SIRT1 can also lay upstream LKB1/AMPK to control lipid metabolism [39].”
BackgroundZhu, Y., Liu, G., Du, X., Shi, Z., Jin, M., Sha, X.-Y., Li, X., Wang, Z., & Li, X. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14965 · Cited by 73
“, 2013), which can transfer long-chain acyl-CoA into the mitochondria for β-oxidation (Hou et al., 2008).”
BackgroundYu, M.-H., Hung, T., Wang, C., Wu, S., Yang, T., Yang, T., Tseng, T., & Wang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313163 · Cited by 79
“Polyphenols have been reported to possess therapeutic potential for dyslipidemia by targeting SIRT1/AMPK signaling, which plays an essential role in the regulation of hepatocyte lipid metabolism [45].”
BackgroundAMPK signaling in skeletal muscle during exercise: Role of reactive oxygen and nitrogen species
Morales-Alamo, D., & Calbet, J. A. L. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.012 · Cited by 72
Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis
Ducheix, S., Lobaccaro, J. A., Martin, P. G. P., & Guillou, H. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.06.004 · Cited by 75
“SIRT1 acts in response to nutrient availabilty as a master switch in lipid and glucose homeostasis (Feige and uwerx, 2007; Hou et al., 2008; Ponugoti et al., 2010).”
Effect of resveratrol on endothelial cell function: Molecular mechanisms
Schmitt, C. A., Heiß, E. H., & Dirsch, V. M. (2010) · BioFactors · doi:10.1002/biof.109 · Cited by 82
“However, in endothelial cells pharmacological inhibition of AMPK had no effect on RV’s SIRT1-dependent induction of the transcriptional regulator KLF2 [22] and there is evidence that at least in some tissues SIRT1 is also acting upstream of AMPK [23,24].”
BackgroundLi, Y., Xu, S., Jiang, B., Cohen, R. A., & Zang, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067532 · Cited by 71
“supported by our previous observation that SIRT1 regulates hepatocyte lipid metabolism by activating AMPK [40] and by the Sinclair group showing that SIRT1 is required for AMPK Figure 8.”
BackgroundSelf-citationChen, K.-H., Cheng, M.-L., Jing, Y.-H., Chiu, D. T.-Y., Shiao, M.-S., & Chen, J.-K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00048.2011 · Cited by 71
Sirtuins inhibitors: The approach to affinity and selectivity
Cen, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.010 · Cited by 76
Li, L., Wang, H., Zhao, S., Zhao, Y., Chen, Y., Zhang, J., Wang, C., Sun, N., & Fan, H. (2022) · Phytotherapy Research · doi:10.1002/ptr.7471 · Cited by 72
“SIRT1, a conserved nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase, plays a prominent role in the regulation of metabolism (Hou et al., 2008), mitochondrial function, and oxidative stress (Chang et al., 2021).”
BackgroundKarpe, P. A., & Tikoo, K. (2014) · Diabetes · doi:10.2337/db13-1267 · Cited by 74
“The lipid metabolism in hepatocytes has been shown to be regulated by SIRT1 through AMPK (67).”
BackgroundZhuo, L., Fu, B., Bai, X., Zhang, B., Wu, L., Cui, J., Cui, S., Wei, R., Chen, X., & Cai, G. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000330077 · Cited by 67
Zhang, H., Li, Y., Su, W., Ying, Z., Zhou, L., Zhang, L., & Wang, T. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600653 · Cited by 72
Recent advances in anti-inflammation via AMPK activation
Xu, Y., Bai, L., Yang, X., Huang, J.-L., Wang, J., Wu, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33670 · Cited by 84
“Activation of the AMPK/SIRT1 pathway is a promising therapeutic target in alcoholic liver disease (ALD) [50,51].”
BackgroundKwon, J. Y., Seo, S. G., Yue, S., Cheng, J., Lee, K. W., & Kim, K. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.014 · Cited by 74
Gisbert, E., Andree, K. B., Quintela, J. C., Calduch-Giner, J. À., Ipharraguerre, I. R., & Pérez‐Sánchez, J. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000228 · Cited by 74
“These results were in agreement with in vitro (54) and in vivo (55) models that have shown that poly-phenols reduce hepatocellular lipid accumulation by means of the regulation of the AMP-activated protein kinase signalling and hepatocyte lipid metabolism.”
Reciprocal Regulation of AMPK/SNF1 and Protein Acetylation
Vančura, A., Nagar, S., Kaur, P., Bu, P., Bhagwat, M., & Vancurova, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113314 · Cited by 75
“Activated AMPK then suppresses lipid accumulation in hepatocytes [92].”
BackgroundBao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
“In an apparent perpetuating cycle, the deacetylation of AMPK kinase LKB1 by SIRT1 concordantly increase AMPK activity [54, 63].”
InfluentialExtra Virgin Olive Oil Phenols down-Regulate Lipid Synthesis in Primary-Cultured Rat-Hepatocytes
Priore, P., Siculella, L., & Gnoni, G. V. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.01.009 · Cited by 67
“However, the effective phenol concentration used in this study is in the μM range and similar phenol concentrations have been shown to exert anti-atherogenic and antioxidant effects in several cell lines [14,47,49,52].”
BackgroundResultChinese herbal medicine in the treatment of nonalcoholic fatty liver disease
Dong, H., Lu, F., & Zhao, L. (2012) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-012-0993-2 · Cited by 72
Extranuclear Sirtuins and Metabolic Stress
Elkhwanky, M., & Hakkola, J. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7270 · Cited by 70
“Furthermore, SIRT1 may be involved in AMPK activation (49, 96).”
Han, X., Cui, Z., Song, J., Piao, H.-Q., Lian, L., Hou, L., Wang, G., Zheng, S., Dong, X.-X., Nan, J., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108794 · Cited by 72
Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy
Kubli, D. A., & Gustafsson, Å. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6322 · Cited by 64
“In response to caloric restriction (starvation), SIRT1 contributes to the induction of autophagy by deacetylating FOXO transcription factors, activating AMPK, and inhibiting mTOR activity (67, 91).”
BackgroundNatural Compounds as Regulators of the Cancer Cell Metabolism
Cerella, C., Radogna, F., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/639401 · Cited by 68
A Redox-resistant Sirtuin-1 Mutant Protects against Hepatic Metabolic and Oxidant Stress
Shao, D., Fry, J., Han, J., Hou, X., Pimentel, D. R., Matsui, R., Cohen, R. A., & Bachschmid, M. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520403 · Cited by 70
“We (46) and others (33, 50), however, found SirT1 expression unchanged in metabolically stressed HepG2 cells (Fig.”
BackgroundSelf-citationLopes Costa, A., Le Bachelier, C., Mathieu, L., Rotig, A., Boneh, A., De Lonlay, P., Tarnopolsky, M. A., Thorburn, D. R., Bastin, J., & Djouadi, F. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt603 · Cited by 61
Zhang, Y., Jin, Q., Li, X., Jiang, M., Cui, B., Xia, K., Wu, Y., Lian, L., & Nan, J. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00944 · Cited by 70
Hajizadeh‐Sharafabad, F., Ghoreishi, Z., Maleki, V., & Tarighat‐Esfanjani, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104477 · Cited by 67
Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction
Wu, L., Zhou, L., Lü, Y., Zhang, J., Jian, F., Liu, Y., Li, F., Li, W., Wang, X. Q., & Guo, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.009 · Cited by 68
Everitt, H., Hu, M., Ajmo, J. M., Rogers, C. Q., Liang, X., Zhang, R., Yin, H., Choi, A., Bennett, E. S., & You, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00309.2012 · Cited by 65
“Whereas SIRT1 stimulates AMPK activity through LKB1, AMPK enhances SIRT1 activity by increasing cellular NAD levels (4, 17, 19).”
BackgroundInfluentialSIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase
Zhang, H., & Wu, M.-R. (2009) · Virus Research · doi:10.1016/j.virusres.2009.08.005 · Cited by 67
Kim, J., Lee, Y., You, Y., Moon, M. K., Yoon, K., Ahn, Y., & Ko, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28141 · Cited by 68
“SIRT1 functions as a novel upstream regulator for AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism.(46) SREBP‐1c is considered as the direct target of SIRT1(34); SREBP‐1c transcription is suppressed by AMPK, and accounts for the decrease in FAS expression in rat hepatocyte ce…”
BackgroundHan, C. Y., Ki, S. H., Kim, Y. W., Noh, K., Lee, D. Y., Kang, B., Ryu, J.-H., Jeon, R., Kim, E. H., Hwang, S. J., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3190 · Cited by 63
“Emerging evidence supports that SIRT1, an NAD-dependent deacetylase, collaborates with AMPK to regulate energy metabolism (16).”
miR-217 Regulates Ethanol-Induced Hepatic Inflammation by Disrupting Sirtuin 1–Lipin-1 Signaling
Yin, H., Liang, X., Jogasuria, A. P., Davidson, N. O., & You, M. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.030 · Cited by 66
Iron regulates glucose homeostasis in liver and muscle via AMP‐activated protein kinase in mice
Huang, J., Simcox, J., Mitchell, T. C., Jones, D., Cox, J. E., Luo, B., Cooksey, R. C., Boros, L. G., & McClain, D. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-216929 · Cited by 67
“Iron overload may result in increased oxidative stress, which in turn regulates SIRT1 activity (26).”
BackgroundInfluentialKetogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus
Elamin, M., Ruskin, D. N., Masino, S. A., & Sacchetti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00263 · Cited by 65
Kelly, G. S. (2010) · PubMed · Cited by 87
Obesity medications in development
Rebello, C. J., & Greenway, F. L. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1705277 · Cited by 62
Fan, N., Zhao, J., Zhao, W., Zhang, X., Song, Q., Shen, Y., Shum, H. C., Wang, Y., & Rong, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.034 · Cited by 66
Duca, F. A., Bauer, P. V., Hamr, S. C., & Lam, T. K. T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.003 · Cited by 64
“…with activation of AMPK in various tissues involve an interactive dependency with another energy sensor, the NAD+-dependent deacetylase sirtuin 1 (SIRT1) (Cantó et al., 2009; Côté et al., 2015; Feige et al., 2008; Fulco et al., 2008; Hou et al., 2008; Lan et al., 2008; Price et al., 2012).”
Yu, J., Sun, L., Liu, W., Zhao, Y.-H., Kang, P., & Yan, B. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.01.027 · Cited by 65
“In addition to allosteric regulation by AMP, AMPK is regulated by AMPK kinases such as proteins LKB1.”
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Castaño, D., Larequi, E., Belza, I., Astudillo, A. M., Martínez‐Ansó, E., Balsinde, J., Argemí, J., Aragón, T., Moreno-Aliaga, M. J., Muntané, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.012 · Cited by 65
“Interestingly, it has been shown that this also occurs with AICAR, which increases AMPK phosphorylation without altering Ser428 phosphorylation of LKB1 [25].”
BackgroundEffects of resveratrol on HepG2 cells as revealed by 1H-NMR based metabolic profiling
Massimi, M., Tomassini, A., Sciubba, F., Sobolev, A. P., Devirgiliis, L. C., & Miccheli, A. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.005 · Cited by 67
Wu, W., Cui, Y., Hong, Y., Li, Y., Wu, Y., Li, G., Li, G., & Wang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15859 · Cited by 65
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
Chen, X., Cai, C., Yu, M., Feng, Z., Zhang, Y.-W., Liu, P., Zeng, H., & Yu, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i45.6607 · Cited by 65
Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review)
Anggreini, P., Kuncoro, H., Sumiwi, S. A., & Levita, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12922 · Cited by 69
“Furthermore, AMPK, which is the natural regulator of ChREBP and SREBP1c, is also affected by SIRT1 activity through an indirect mechanism by deacetylating the upstream kinase of AMPK, LKB1 (18,44).”
InfluentialNatural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro.
Abdulla, A., Zhao, X., & Yang, F. (2013) · PubMed · Cited by 79
Grabacka, M., Pierzchalska, M., & Reiss, K. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030009 · Cited by 58
Dogra, S., Kar, A. K., Girdhar, K., Daniel, P. V., Chatterjee, S., Choubey, A., Ghosh, S., Patnaik, S., Ghosh, D., & Mondal, P. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.013 · Cited by 62
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Oirdi, M. E. (2024) · Pharmaceuticals · doi:10.3390/ph17060692 · Cited by 69
“This condition is distinguished by inflammation of the synovial tissue, swelling, the formation of autoantibodies, and the loss of cartilage and bone.”
BackgroundEffects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Heebøll, S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.188 · Cited by 60
Purushotham, A., Xu, Q., & Li, X. (2012) · The FASEB Journal · doi:10.1096/fj.11-195172 · Cited by 59
Zhao, Z., Yan, J., Huang, L., & Yang, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116373 · Cited by 61
Metadata
- Authors
- Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., Cohen, R. A., & Zang, M.
- Affiliations
- Boston University (US)
- Institut de Recherches Internationales Servier (France) (FR)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 283
- Issue
- 29
- Pages
- 20015-20026
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2459285
- OpenAlex
- W1973163466
- Cited by
- 778
- References
- 57
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 26 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 38 · 2019: 42 · 2018: 52 · 2017: 49 · 2016: 50 · 2015: 50 · 2014: 60 · 2013: 71 · 2012: 54
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4458 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Servier
- National Institutes of Health (P01 HL 68758)
- Institut de Recherches Servier
- National Institute on Aging (R01 AG-27080, R01AG027080)
- National Heart, Lung, and Blood Institute (P01HL068758, P01-HL68758)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 76942, R01DK076942)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- SIRT1, AMPK, LKB1, polyphenols, resveratrol, hepatocyte lipid metabolism, hepatic lipid accumulation, fatty acid synthase, acetyl-CoA carboxylase, high glucose, dyslipidemia, atherosclerosis, type 1 diabetes, CaMKKβ
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Cell Line, Enzyme Activation, Flavonoids, Glucose, Humans, Multienzyme Complexes, Phenols, Signal Transduction, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Hepatocytes, RNA Interference, Sirtuins, Lipid Metabolism, Mice, Focal Adhesion Protein-Tyrosine Kinases, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases, Sirtuin 1, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.